Cardiovascular polypharmacy for atherosclerotic cardiovascular disease, therapeutic goals and targets: Are we doing the right thing?
Crossref DOI link: https://doi.org/10.31762/AHJ1926.0201
Published Online: 2019-05-27
Update policy: https://doi.org/10.31762/ahj-cm-policy
Quek, David KL